EXFY · Expensify
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $2.23
Note written ·
Price against the kill line
17.5% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $2.23, on record since 11 November 2026. The shares are down 18.9% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $2.23, the close on 5 November 2026 before the third-quarter results, which would show the shares leading again; fourth-quarter revenue above the third quarter's $33.0 million with paid members above 630,000 would also show it.
Research onlyNot in the portfolio.
Key figures from the filings · Technology
Quarter to 30 September 2026, filed 5 November 2026
- Revenue, latest quarter ($M)
- 33.0
- Revenue, change on a year (%)
- −5.8
- Gross margin (%)
- 45.2
- Operating margin (%)
- −8.1
All filed numbers
What Expensify reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 33.0 | −5.8 | 45.2 | −8.1 |
| first filed | 33.9 | −5.3 | 48.2 | −8.6 |
| first filed | 34.0 | −5.8 | 47.6 | −5.8 |
| first filed | 35.2 | −4.9 | 49.2 | −11.2 |
| first filed | 35.1 | −1.0 | 49.6 | −6.4 |
| first filed | 35.8 | +7.4 | 51.9 | −28.9 |
| Pre-tax income ($M) | −2.3 |
| Net income ($M) four quarters: −16.6 | −3.3 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | −1.1 |
| Operating cash flow ($M) | Not available |
| Capital spending ($M) | Not available |
| Free cash flow ($M) | Not available |
| Cash and short-term investments ($M) | 63.7 |
| Debt ($M) | Not available |
| Net cash, cash less debt ($M) | Not available |
| Deferred revenue ($M) +31.1% on a year | 0.6 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 11.2 |
| Inventory ($M) | Not reported |
| Shareholders' equity ($M) | 138 |
| Market value ($M) | 168 |
| Enterprise value, market value plus net debt ($M) | Not available |
| Enterprise value to sales (×) | Not available |
| Enterprise value to operating income (×) | Not available |
| Price to earnings (×) | Not meaningful |
| Price to book value (×) | 1.2 |
| Free-cash-flow yield (%) | Not available |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 1.1% of shares outstanding sold short, 2.6 days of average trading to cover, −5.0% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $989K | $0 |
| 12 monthsfrom | $3.1M | $431K |
The thesis
Expensify's shares are more likely to lag the S&P 500 over the next three months because company-wide revenue is still shrinking while the new product grows. The fourth-quarter report, expected in early 2027, decides whether New Expensify revenue is large enough to turn the total.
Expensify's 8-K for the quarter ended 30 September 2026 shows net revenue of $33.0 million, down 6% from $35.1 million a year earlier and below the second quarter's $33.9 million. Paid members were 630,000, down 2% year over year and down from 640,000 in the second quarter. New Expensify revenue rose 30% from the second quarter and 212% from a year earlier. The company gave no revenue or earnings guidance for the fourth quarter.
The price already reflects the miss: the shares closed at $1.78 on 11 November 2026, down 19.8% over three months, after sales of $33.021 million fell short of the $33.864 million analyst estimate (Benzinga, 5 November 2026). Free cash flow is the part of the case that improved.
Bullish and bearish views on Expensify, Inc.
The bull case on Expensify, Inc. (EXFY), in brief: cash generation keeps improving. The bear case: revenue missed and fell sequentially.
Bull case
- Cash generation keeps improving. Third-quarter free cash flow was $3.3 million against $1.2 million a year earlier, and operating cash flow was $4.0 million (Q3 8-K, 5 November 2026). The company raised its fiscal 2026 free-cash-flow guidance to $13.5 million–$15.5 million, up $1.5 million from the prior range.
- New Expensify is growing fast. Its revenue rose 212% year over year and 30% from the second quarter (Q3 8-K, 5 November 2026). The release gave no annual recurring revenue figure for the quarter.
- Adjusted earnings beat. Adjusted earnings per share were $0.03 against a $0.02 estimate (Benzinga, 5 November 2026), even as revenue missed.
- Buybacks continue with cash on hand. The company repurchased 722,121 Class A shares for about $1.3 million in the third quarter and $10.5 million over nine months, and held $63.7 million of cash and equivalents at 30 September 2026, plus $49.3 million of restricted cash (Q3 8-K).
- A new distribution partner. Expensify said on 5 November 2026 that it entered a referral agreement under which Visa can refer eligible clients and corporate card programs to Expensify. Terms were not disclosed.
Bear case
- Revenue missed and fell sequentially. Q3 sales of $33.021 million missed the $33.864 million estimate (Benzinga, 5 November 2026) and sit below Q2's $33.9 million. Revenue fell 6% year over year after a 5% fall in the second quarter.
- Losses widened and profit measures slipped. GAAP net loss was $3.3 million, or $0.04 per share, against $2.3 million, or $0.03, a year earlier. Non-GAAP net income was $3.1 million against $4.3 million, and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, adjusted) was $6.1 million against $6.5 million (Q3 8-K).
- Paid members are falling. The count of 630,000 is 10,000 below the second quarter and 2% below the prior year (Q3 8-K, 5 November 2026).
- No forward revenue guide. The release offered only the free-cash-flow range and estimated fourth-quarter stock-based compensation of $5.8 million–$7.8 million. No company forecast shows whether legacy declines are slowing.
- The post-results slide has continued. The shares closed at $2.38 on 4 November 2026, $2.05 on 6 November 2026 and $1.72 on 10 November 2026 (closing prices), and were at $1.78 on 11 November 2026.
Price setup
The shares closed at $1.78 on 11 November 2026. That is 36.7% below the 52-week intraday high of $2.81 set on 10 August 2026 and below the 50-day average of $2.32. It is above the 200-day average of $1.63, the nearest moving-average level under the price (adjusted daily closes, as of 11 November 2026).
The 52-week closing low is $0.75, set on 17 March 2026. The close of $1.72 on 10 November 2026 is the lowest close since the results; a close under the 200-day average would be the first since the shares recovered above it.
The 50-day average is falling toward the price, and the shares have closed below it since 6 November 2026. Regaining it would require a recovery of the results-week drop.
Catalysts ahead
- ~February 2027 (est.): Q4 and full-year 2026 report; date not company-confirmed. Shows whether New Expensify growth lifts total revenue above Q3's $33.0 million and whether paid members stabilize near 630,000.
What would change the view
A daily close above $2.23, the close on 5 November 2026 before the third-quarter results, which would show the shares leading again; fourth-quarter revenue above the third quarter's $33.0 million with paid members above 630,000 would also show it.
What it trades with
Expensify trades with small-cap software and fintech names that sell to small businesses, and it moves on its own quarterly results more than on sector news. Its Visa referral agreement and Claude connector link the business to payments and AI distribution, and neither has yet produced a disclosed revenue figure. Peer expense-management and corporate-card providers are the nearest comparison for member and revenue trends.
The evidence, claim by claim (8)
- Q3 2026 net revenue was $33.0 million, down 6% from $35.1 million a year earlier; paid members were 630,000, down 2%. Expensify Q3 2026 8-K, exhibit 99.1 · as of
- New Expensify revenue rose 30% from Q2 and 212% year over year. Expensify Q3 2026 8-K, exhibit 99.1 · as of
- Q3 GAAP net loss was $3.3 million ($0.04 per share) versus $2.3 million a year earlier; adjusted EBITDA was $6.1 million, an 18% margin. Expensify Q3 2026 8-K, exhibit 99.1 · as of
- Q3 free cash flow was $3.3 million; fiscal 2026 free-cash-flow guidance was raised to $13.5 million–$15.5 million. Expensify Q3 2026 8-K, exhibit 99.1 · as of
- Q3 sales of $33.021 million missed the $33.864 million analyst estimate; adjusted EPS of $0.03 beat the $0.02 estimate. Benzinga · as of
- Expensify entered a referral agreement under which Visa can refer eligible clients and corporate card programs to Expensify; terms not disclosed. Benzinga / Expensify Q3 2026 8-K · as of
- Cash and equivalents were $63.7 million at 30 September 2026, plus $49.3 million restricted cash; 722,121 Class A shares were repurchased in Q3 for about $1.3 million. Expensify Q3 2026 8-K, exhibit 99.1 · as of
- The shares closed at $1.78 on 11 November 2026, 36.7% below the 52-week intraday high of $2.81 (10 August 2026); 3-month change −19.8%. Daily closes (quoted) · as of
Sources
- Expensify, Inc. - Form 8-K - FY2026 · sec.gov
- Expensify Announces Q3 2026 Results · morningstar.com ·
- Expensify Inc Reports Q3 2026 Results: Revenue Misses Estimates at $33.0 Million, GAAP EPS of -$0.04 Outperforms Expectations · gurufocus.com
- Expensify (EXFY) Q3 2026 Earnings Call Transcript · fool.com ·